Optimal treatment sequencing in anemic myelofibrosis

Описание к видео Optimal treatment sequencing in anemic myelofibrosis

During the Clinical Trial Club live webinar, “Treatment sequencing for anemic myelofibrosis,” myeloproliferative neoplasms expert, Angela Fleischman, discussed optimal treatment sequencing in anemic myelofibrosis. She began by outlining when to initiate therapy and first-line therapy considerations, before discussing treatment options for relapsed/refractory disease.
Fleischman then reviewed key data from recent and ongoing clinical trials, including a phase II trial investigating luspatercept and studies evaluating pacritinib.

Комментарии

Информация по комментариям в разработке

Похожие видео